News and Updates
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
MSCA Presidency Conference "Researchers' careers: multiple pathways" 18 and 19 April 2024: web stream available
In case you were not able to register for onsite attendance in Mons at the Marie Skłodowska-Curie Actions (MSCA) Presidency Conference 2024 on the multiple pathways of researchers' careers rest assured that you can participate anyway. Did you know that it is possible to watch the conference from anywhere in the world on your screen?
The whole conference except the parallel sessions on 18 April (workshop 1, 2 & 3 and roundtable 2) are web streamed live. Check out the biographies of all speakers at the conference and the 15 MSCA Falling Walls Lab contestants. The full agenda and web stream of the conference are available on the MSCA Presidency Conference website here.
Related News
|
2024-10-24
|
4 weeks ago |
Survey on the added value of MSCA PhDs |
|
2024-10-04
|
1 month ago |
Joint statement ‘We need much more MSCA!’ published |
|
2024-09-27
|
1 month ago |
Number of submitted proposals MSCA Cofund 2024 call |
|
2024-09-20
|
2 months ago |
Marie Skłodowska-Curie Actions’ Newsletter latest edition |
|
2024-09-12
|
2 months ago |
Number of submitted proposals - MSCA Postdoctoral Fellowships 2024 call – deadline 11... |
|
2024-09-02
|
2 months ago |
Horizon Europe Impact training session and Proposal workshop coming up this Autumn |
|
2024-08-23
|
3 months ago |
Apply now to attend the 74th Lindau meeting on chemistry |
|
2024-07-15
|
4 months ago |
MSCA4Ukraine second call for applications: submission platform for host organisations... |
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Latest News
1484 articles available search in articlesDeployment: Best use of technologies
Procurement: Better Internet for Kids (BIK) Platform – EU Coordination
The European Commission (DG CONNECT) has launched the following procurement procedure: Better Internet for Kids (BIK) Platform – EU Coordination (EC-CNECT/LUX/2024/OP/0097) The EU-funded Better Internet for Kids portal (at https://better-internet-for-kids.europa.eu) and the associated coordination tasks are the main subject of th... read more
Digital, Industry & Space AI, data & cloud
Commission consultation on AI Act prohibitions and AI system definition
The European Commission’s Artificial Intelligence (AI) Office has launched a targeted stakeholders consultation process on the future guidelines on the AI system definition and the implementation of AI practices that pose unacceptable risks under the AI Act. The guidelines will help national competent authorities as well as providers and dep... read more
Digital, Industry & Space AI, data & cloud
First draft of General-Purpose Artificial Intelligence Code of Practice
The European Commission has published the first draft of the General-Purpose Artificial Intelligence (AI) Code of Practice. The rules governing general-purpose AI models under the AI Act will come into application in August 2025. The Code of Practice aims to facilitate the proper implementation of these rules and will play a crucial role in guidin... read more
Testimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
